Android app Apple app link

Revance Therapeutics, Inc. (RVNC) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/17/2024 Mizuho Securities Vamil Divan $6.66 $5.96   11.84%
05/10/2024 Piper Sandler David Amsellem $11.00 $3.74   194.51%
05/10/2024 H.C. Wainwright Douglas Tsao $11.00 $4.29   156.41%
05/10/2024 Mizuho Securities Vamil Divan $8.00 $3.73   114.47%
09/20/2023 Needham Serge Belanger $35.00 $13.48   159.64%
08/25/2022 Wells Fargo Jacob Hughes $24.00 $21.26   12.89%

Revance Therapeu FAQ's

Revance Therapeu has been rated by research analysts at Mizuho Securities, Piper Sandler, H.C. Wainwright, Needham, Barclays, Wells Fargo in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.